ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2001–2005
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Current Drug Targets: Immune, Endocrine and Metabolic Disorders
Current Drug Targets: Immune, Endocrine and Metabolic Disorders is not currently indexed in Scopus. Published by Bentham Science Publishers.
Checked against the index lists dated .
ISSN 1568-0088Verify ISSN ↗
Publisher: Bentham Science Publishers
Scopus · Inactive
0
Indexed in
Cost to publish: No APC data — check the publisher
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Current Drug Targets: Immune, Endocrine and Metabolic Disorders indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2001–2005).
What is the impact factor of Current Drug Targets: Immune, Endocrine and Metabolic Disorders?
Current Drug Targets: Immune, Endocrine and Metabolic Disorders has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Current Drug Targets: Immune, Endocrine and Metabolic Disorders and what is its ISSN?
Current Drug Targets: Immune, Endocrine and Metabolic Disorders is published by Bentham Science Publishers. Its ISSN is 1568-0088.
Is Current Drug Targets: Immune, Endocrine and Metabolic Disorders in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Current Drug Targets: Immune, Endocrine and Metabolic Disorders open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Current Drug Targets: Immune, Endocrine and Metabolic Disorders for 5 years, between 2001 and 2005. Coverage ended in 2005, 21 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 205 works and 5,441 citations for the title. OpenAlex attributes papers to this title as late as 2019, 14 years after Scopus coverage ended in 2005. That may reflect a changed ISSN or merged records rather than continued publishing, so confirm the journal's current status directly before submitting.
How well cited is Current Drug Targets: Immune, Endocrine and Metabolic Disorders? — open metrics via OpenAlex
Current Drug Targets: Immune, Endocrine and Metabolic Disorders has an h-index of 40 and a 2-year mean of 0 citations per paper (OpenAlex).
40
h-index
0
2-yr mean citations
132
i10-index
205
works indexed
5,441
total citations
Current Drug Targets: Immune, Endocrine and Metabolic Disorders published 1 papers in 2019; its busiest recent year was 2005 with 49. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Current Drug Targets: Immune, Endocrine and Metabolic Disorders? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2005. 1 retracted paper is recorded (4.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2005
- Retracted papers 1 · 4.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Bentham Science Publishers
Bentham Science Publishers has 239 other titles in our data; 119 are currently indexed in Scopus.
Journal Scopus status
Adolescent Psychiatry Active Anti-Cancer Agents in Medicinal Chemistry Active Anti-Infective Agents Active Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry Active Cardiovascular and Hematological Disorders - Drug Targets Active Central Nervous System Agents in Medicinal Chemistry Active Related journals
8 journals Journal Indexed in
Current Drug Targets - Infectious Disorders Not in these indexes Current Drug Therapy Scopus Q3 WoS ESCI Current Enzyme Inhibition Scopus Q4 Current Gene Therapy Scopus Q1 WoS SCIE Current Genomics Scopus Q3 WoS SCIE Current Green Chemistry Scopus Q3 WoS ESCI Current HIV Research Scopus Q3 WoS SCIE Current Hypertension Reviews Scopus Q3 WoS ESCI
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.